Healthcare Select Sector SPDR (XLV) 55.71 $XLV Chart of

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthcare Select Sector SPDR (XLV) 55.71 $XLV

Chart of the Day: Returns by Sector - Real Time Insight
Todd Bunton - Zacks Investment Research - Tue Apr 08, 11:40AM CDT
Sector returns show a "flight to safety" so far this year. But will that trend continue? Let us know what you think!

Utilities, Health Care Leading ETF Sectors
at The Street - Wed Apr 02, 9:15AM CDT
Here are some investments to get exposure to broad sectors in the economy.

Health-Care Stocks: Growing Like Gangbusters
Selena Maranjian, The Motley Fool - Motley Fool - Sat Mar 15, 8:30AM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some health-care stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Health Care Select Sector SPDR...

ETF Sector Rotation: Industrials Out, Healthcare In - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 11:00AM CDT
Which ETFs have been seeing a surge in assets lately?

Stock Market News for March 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 9:06AM CST
Benchmarks ended Thursday’s trading session on a mixed note

Watch Out! These 8 ETFs Have Negative Weekly Chart Profiles
at The Street - Tue Feb 11, 10:22AM CST
Energy and finance sector SPDRs are among those starting the week badly.

2 Shocking Sectors That Defied the Stock Market's January Plunge
Dan Caplinger, The Motley Fool - Motley Fool - Sat Feb 01, 10:31AM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. The S&P 500 lost about 3.6% in January, with...

3 Top Ranked Healthcare ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jan 28, 1:04PM CST
These health care ETFs could be winners in 2014.

Obamacare Boosts Health Funds
at The Street - Mon Jan 27, 10:26AM CST
Pharmaceutical and hospital stocks rally as more consumers gain insurance.

Healthcare ETFs in Focus on JNJ Beat - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jan 22, 12:15PM CST
JNJ's Q4 results beat on top and bottom line but the outlook was slightly weak.

Where Do You Rotate? - Real Time Insight
Kevin Cook - Zacks Investment Research - Tue Jan 21, 10:34AM CST
Will the sector leaders continue to lead, while the laggards lag?

The ETF No One Is Talking About, Including Its Issuer
at The Street - Tue Jan 21, 8:28AM CST
Smaller fund companies success hinders on communication with fund holders.

3 Health Care Investments Immune From FDA Scrutiny
Seth Robey, The Motley Fool - Motley Fool - Tue Dec 31, 11:19AM CST
Clinical trial jargon and the "yea" or "nay" decisions of the Food and Drug Administration can seem like intimidating obstacles to finding successful health care investments. But with the Health Care Select Sector SPDR ETF outperforming the...

Play Safe with These 3 ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Nov 08, 9:00AM CST
These ETFs can provide stability to the portfolio during times of turmoil.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 316

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Stretch Zone Expands Horizons with Canadian Studio Launch

Updated Category News Views 214

Stretch Zone's Exciting New Chapter in Canada Stretch Zone, a trailblazer in the realm of assisted stretching, has embarked on a significant milestone by opening its first studio in Canada. This new location is not just a store but a powerful symbol of the brand's commitment to enhance flexibility and mobility in communities beyond the United States. The Vision Behind the...

Continue Reading
Eilean Therapeutics Unveils Groundbreaking JAK2 Inhibitor ZE74-0282

Updated Category News Views 585

New Frontiers in JAK2 Inhibition by Eilean Therapeutics Eilean Therapeutics LLC, a pioneering biotechnology company, is set to make waves in cancer treatment with its latest development, ZE74-0282, a wild-type-sparing JAK2-JH2/V617F inhibitor. The company has announced an exciting presentation at the upcoming American Society of Hematology (ASH) Annual Meeting, focusing...

Continue Reading
PodcastOne Extends LadyGang Contract as It Approaches 1000 Episodes

Updated Category News Views 116

PodcastOne Renews its Agreement with LadyGang Podcast PodcastOne, a key player in the podcasting world, is thrilled to announce the renewal of its contract with the immensely popular LadyGang podcast, hosted by Keltie Knight, Becca Tobin, and Jac Vanek. Launched in 2015 on PodcastOne, this engaging podcast has resonated with millions of listeners and is gearing up to...

Continue Reading
BCA Research Warns Upcoming Rate Cuts May Be Insufficient

Updated Category News Views 73

BCA Research Warns Rate Cuts May Arrive Too Late BCA Research has expressed concerns about the upcoming rate cuts, suggesting they might not effectively address a potential recession. The firm points out that the effects of monetary policy often lag, meaning the economy is still grappling with the repercussions of previous tightening measures. Market Sentiments and...

Continue Reading
SOMOS Pilates Nashville: A Vibrant Rebranding Journey

Updated Category News Views 235

SOMOS Pilates Nashville: A Vibrant Rebranding Journey In an inspiring shift, Studio Pilates Nashville has announced its rebranding as SOMOS Pilates Nashville. This transition marks a significant evolution, aimed at celebrating the studio's growth and commitment to community-centered movement practices. Welcoming a New Identity The rebranding initiative reveals more than...

Continue Reading